Scientists in the US have developed a vaccine to fight ovarian cancer, and it has shown encouraging results in preliminary trials.
The vaccine developed by scientists led by Kunle Odunsi at the Roswell Park Cancer Institute in Buffalo enhances the body's own immune response to the cancer, reported the online edition of BBC News.
The researchers tested the vaccine in women with epithelial ovarian cancer, a type of cancer that originates on the covering of the ovaries.
Low-fat Diet Reduces Ovarian Cancer Risk
According to a study published online October 9 in the Journal of the National Cancer Institute a low-fat diet might decrease the risk of ovarian cancer in postmenopausal women.
Advertisement
"There is now compelling evidence that the immune system has the capacity to recognise and kill ovarian cancer cells. We are confident that the vaccine will eventually be widely available," Odunsi said.
Ovarian cancer is the development of a tumour on or within an ovary. It usually happens in women who are over 50 years of age but it can also affect younger women. Its cause is unknown. Treatment is usually surgery followed by treatment with medicines.
![Ovarian Cancer Patients]( "Ovarian Cancer Patients")
An experimental drug called pertuzumab may help prolong the survival time for women with recurrent ovarian cancer, a University of Alabama at Birmingham doctor has said.
Most patients with advanced disease respond to drug treatments but more than 70 percent die from a recurrence of the cancer within five years of diagnosis.
It is the fourth most common type of cancer in women and fifth leading cause of cancer death in the US. In India, according to the Indian Council of Medical Research, the crude incidence rate of this cancer is 4.2 per 100,000 women.
Source: IANS
SRM /B
Ovarian Cancer Patients' Survival Time Increased With Experimental Drug
An experimental drug called pertuzumab may help prolong the survival time for women with recurrent ovarian cancer, a University of Alabama at Birmingham doctor has said.
Advertisement
Most patients with advanced disease respond to drug treatments but more than 70 percent die from a recurrence of the cancer within five years of diagnosis.
It is the fourth most common type of cancer in women and fifth leading cause of cancer death in the US. In India, according to the Indian Council of Medical Research, the crude incidence rate of this cancer is 4.2 per 100,000 women.
Source: IANS
SRM /B
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest Cancer News
The first large-scale, collaborative, open analysis of genomic data provides a cloud-based resource for researchers looking for more comprehensive data on pediatric brain tumors.
The mission of Axiom Space incorporated numerous experiments focusing on human stem cell aging, inflammation, and cancer within the laboratory situated in the low Earth orbit.
Providing a sustained supply of hydrogen sulfide to cancer cells, could be a remodeling strategy to improve photothermal therapy efficacy while minimizing side effects.
Colon cancer's hidden link revealed in microbiome study.
Breast cancer patients in the obese or overweight category can greatly benefit from a telephone-based weight management program in achieving significant weight loss.